Sleep Disturbance Clinical Trial
Official title:
Sleep Wellness Program - University REST
This study study aims to examine relationships between sleep and mental health and well-being among a more heterogeneous sample of students and apply the REST intervention to this group to determine whether we can improve sleep in this group and whether changes in sleep are associated with improvements in mental health.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | March 15, 2021 |
Est. primary completion date | March 15, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - at least a score of 3 on the Pittsburgh Sleep Quality Index (indicating at least a minor problem with sleep quality). - a score of at least 6 on the Epworth Sleepiness Scale (indicating at least moderate sleepiness). - a score of at least 7 on the Insomnia Severity Index (indicating at least mild insomnia), or habitual sleep duration of less than 6 hours per night (indicating insufficient sleep). Exclusion Criteria: - score less than a 3 on the Pittsburgh Sleep Quality Index. - score less than a 6 on the Epworth Sleepiness Scale. - score less than a 7 on the Insomnia Severity Index. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Arizona |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Insomnia Severity Index (ISI) | The Insomnia Severity Index is a brief screening assessment tool designed to evaluate insomnia. Time frame: past 2 weeks. Measuring 7 items. Scores range from 0-28. Scores interpret as follow: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28). The higher the result, the more severe the insomnia is. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in the Pittsburgh Sleep Quality Index (PSQI) | A subjective measure of sleep. Score ranges from 0-21. Higher scores indicate worse sleep quality. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in the Fatigue Severity Scale (FSS) | The Fatigue Severity Scale is a self-reported scale measuring fatigue. Time frame: previous week. Measuring 9 items. Scores ranges from 9-63. Levels of fatigue interpret as follow: not suffering from fatigue (<36); presence of fatigue (>36). The higher the score, the greater fatigue is perceived. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in the Epworth Sleepiness Scale (ESS) | The Epworth Sleepiness Scale is a self-administered questionnaire that's routinely used to assess daytime sleepiness. Time frame: previous 2 weeks. Measuring 8 items. Score ranges from 0-24. The higher the score, the higher average sleep propensity in daily life (ASP) or daytime sleepiness is. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in the Assessment of Sleep Environment (ASE) | A questionnaire that measures the degree to which the physical environment disturbs sleep. It contains 13 items with scores ranging from 0-Strongly Disagree to 3-Strongly Agree. Higher scores suggest less optimal sleep environment. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in the Center for Epidemiologic Studies Depression Scale (CES-D) | A short self-report scale designed to measure depressive symptomatology. Time frame: previous week. Measuring 20 items comprising 6 scales. Score ranges from 0-60. The higher the score is the greater the presence of depressive symptomatology. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in the Patient Health Questionnaire (PHQ-9) | A self-administered questionnaire for common mental disorders, specifically in to the depression module. Time frame: past 2 weeks. Measuring 9 items. Scores ranges from 0-27. Levels of depression measure as follow: minimal (0-4); mild (5-9); moderate (10-14); moderately severe (15-19); severe (20-27). | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in Generalized Anxiety Disorder (GAD-7) | A brief self-report scale to identify probable cases of generalized anxiety. Time frame: past 2 weeks. Measuring 7 items. Scores ranges from 0-21. Levels of anxiety measure as follow: mild (0-9); moderate (10-14); severe (>15). The higher the score the greater presence of generalized anxiety. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Primary | Changes in Perceived Stress Scale (PSS) | A subjective scale measuring perceived stress. Measuring 10 items. Time frame: previous month. Score ranges from 0-40. Levels of stress measure as follow: low stress (0-13); moderate stress (14-26); high perceived stress (27-40). The higher the score, the greater stress is perceived. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Secondary | National College Health Assessment (NCHA) Mental Health Item | The NCHA Mental Health Item contains two brief questions regarding adapting after changes/hardships occur. The scores range from 0-Not at all true to 4-True all the time. A higher score equates to greater ability to adapt after changes. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Secondary | Columbia Suicide Severity Rating Scale | The Columbia Suicide Severity Rating Scale (CSSRS) is a scale containing 16 items which measures suicidality in 3 distinct sections: severity, intensity, and behavior. Answers are "yes" or "no", and scores are determined based on yes/no responses to each question and an added sum of intensity of ideation, ranging from 2-25 with higher scores meaning more intense suicide ideation. | Change from baseline to post-intervention, around 8 weeks after baseline | |
Secondary | World Health Organization (WHO) Performance Questionnaire Item A9 | Change from baseline to post-intervention, around 8 weeks after baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04959214 -
The Effect Of Progressıve Relaxatıon Exercıses
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Completed |
NCT05555186 -
The Effects of Bright Light Therapy on Adolescent's Sleep Quality and Well-being
|
N/A | |
Completed |
NCT05093465 -
A Comparison of Two Behavioral Sleep Interventions Among College Students (ProjectTECH)
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Completed |
NCT04566822 -
Calm Sleep Coaching
|
N/A | |
Not yet recruiting |
NCT06406309 -
Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD
|
N/A | |
Recruiting |
NCT00860756 -
Sleep Disturbance in Deployed Soldiers
|
Phase 0 | |
Recruiting |
NCT05699837 -
Alpha Entrainment for Pain and Sleep (Extension)
|
N/A | |
Completed |
NCT06108115 -
Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder
|
N/A | |
Completed |
NCT05511818 -
Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes
|
N/A | |
Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
Not yet recruiting |
NCT06104280 -
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
|
N/A | |
Enrolling by invitation |
NCT04290650 -
Sleep Disturbances in Patients With Psychotic Symptoms (AkuSleep)
|
N/A | |
Recruiting |
NCT04207502 -
Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Health Aging
|
||
Suspended |
NCT03908905 -
Sleep Disturbances and Chronic Widespread Pain
|
||
Completed |
NCT03269760 -
Multimodal Sleep Pathway for Shoulder Arthroplasty
|
Phase 1 | |
Completed |
NCT04990206 -
Improving Sleep Health in Adults With Overweight or Obesity
|
N/A | |
Completed |
NCT03112824 -
Functional Assessment of Ashwagandaha Root Extract During Weight Loss
|
N/A |